methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate

• ChemBase ID: 179713
• Molecular Formular: C46H58N4O9
• Molecular Mass: 810.97412
• Monoisotopic Mass: 810.42037946
• SMILES: [C@@]1(c2c(c3c([nH]2)cccc3)CCN2C[C@](C[C@H](C1)C2)(O)CC)(c1cc2[C@@]34[C@H]([C@]([C@@H]([C@]5([C@@H]3N(CC4)CC=C5)CC)OC(=O)C)(C(=O)OC)O)N(c2cc1OC)C)C(=O)OC
• Canonical SMILES: COc1cc2N(C)[C@@H]3[C@@]4(c2cc1[C@]1(C[C@@H]2CN(CCc5c1[nH]c1c5cccc1)C[C@](C2)(O)CC)C(=O)OC)CCN1[C@H]4[C@@]([C@H]([C@]3(O)C(=O)OC)OC(=O)C)(CC)C=CC1
• InChI: InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37+,38-,39-,42+,43-,44-,45+,46+/m1/s1
• InChIKey: JXLYSJRDGCGARV-XQKSVPLYSA-N

NAMES AND DATABASE IDS

Names

• IUPAC name: methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo[13.3.1.0^4,^1^2.0^5,^1^0]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0^1,^9.0^2,^7.0^1^6,^1^9]nonadeca-2,4,6,13-tetraene-10-carboxylate
• IUPAC Traditional name: methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo[13.3.1.0^4,^1^2.0^5,^1^0]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0^1,^9.0^2,^7.0^1^6,^1^9]nonadeca-2,4,6,13-tetraene-10-carboxylate
• Synonyms: Vincaleukoblastine; Vincaleucoblastine; Vinblastine

Database IDs

• CAS Number: 865-21-4
• PubChem SID: 164235623
• PubChem CID: 241903

CALCULATED PROPERTIES

• Acid pKa: 10.869524
• H Acceptors: 9
• H Donor: 3
• LogD (pH = 5.5): -1.6706752
• LogD (pH = 7.4): 1.8057727
• Log P: 4.1831455
• Molar Refractivity: 222.4206 cm^3
• Polarizability: 87.76486 Å^3
• Polar Surface Area: 154.1 Å^2
• Rotatable Bonds: 10
• Lipinski's Rule of Five: false

PROPERTIES

Pharmacology Properties

• Mechanism of Action: Binds tubulin, inhibiting the assembly of microtubules

Product Information

• Biological Source: Alkaloid from Vinca rosea ( Catharanthus roseus ) (Apocynaceae)
• Application(s): Antineoplastic agent; Used widely in the treatment of Hodgkin's disease and other lymphomas

REFERENCES

• Aldrich Library of Infrared Spectra, 3rd edn., 1981, 1511H, (ir)
• Neuss, N. et al., J.A.C.S., 1959, 81, 4754; 1962, 84, 1509; 1964, 86, 1440, (uv, ir, pmr, struct)
• Svoboda, G.H. et al., J. Pharm. Sci., 1964, 53, 1227
• Bommer, P. et al., J.A.C.S., 1964, 86, 1439, (ms)
• Moncrief, J.W. et al., J.A.C.S., 1965, 87, 4963, (cryst struct)
• Burns, J.H., Anal. Profiles Drug Subst., 1972, 1, 443, (rev, uv, ir, pmr, anal)
• Wenkert, E. et al., J.A.C.S., 1973, 95, 4990
• Catharanthus Alkaloids, (Eds, Taylor, W.I. et al), M. Dekker, 1975, (pharmacol)
• Wenkert, E. et al., Helv. Chim. Acta, 1975, 58, 1560, (cmr)
• Sieber, S.M. et al., Cancer Treat. Rep., 1976, 60, 1127, (pharmacol)
• Dorman, D.E. et al., Org. Magn. Reson., 1976, 8, 413, (cmr)
• Atta-ur-Rahman et al., Z. Naturforsch., B, 1976, 31, 1416, (rev)
• Kutney, J.P., J. Nat. Prod., 1977, 40, 107, (rev)
• Hassam, S.B. et al., Tet. Lett., 1978, 1681, (biosynth)
• Potier, P. et al., J.A.C.S., 1979, 101, 2243, (synth)
• Brade, W. et al., Contrib. Oncol., (Eds). Vindesine. S. Karger, Basel, Switz., 1981, 6, (book)
• Baxter, R.L. et al., Chem. Comm., 1982, 791, (biosynth)
• Kutney, J.P. et al., Helv. Chim. Acta, 1982, 65, 2088, (biosynth)
• McLauchlan, W.R. et al., Tetrahedron, 1983, 39, 3777, (biosynth)
• Magnus, P. et al., Stud. Org. Chem. (Amsterdam), 1986, 25, 203; 257, (synth, revs)
• Endo, T. et al., Planta Med., 1987, 53, 479
• Kutney, J.P. et al., Heterocycles, 1988, 27, 1845, (synth)
• Kuehne, M.E. et al., Alkaloids (N.Y.), 1990, 37, 77, (synth, rev)
• Neuss, N. et al., Alkaloids (N.Y.), 1990, 37, 229, (pharmacol)
• Magnus, P. et al., J.A.C.S., 1990, 112, 8210; 1992, 114, 10232, (synth)
• Kuehne, M.E. et al., J.O.C., 1991, 56, 513, (synth)
• Muhtadi, F.J. et al., Anal. Profiles Drug Subst., 1992, 21, 611, (rev)
• Bornmann, W.G. et al., J.O.C., 1992, 57, 1752, (synth)
• Martindale, The Extra Pharmacopoeia, 30th edn., Pharmaceutical Press, 1993, 504
• Parish, C.A. et al., Tetrahedron, 1998, 54, 15739-15759, (cd)
• Yokoshima, S. et al., J.A.C.S., 2002, 124, 2137-2139, (synth)
• Hardouin, C. et al., Org. Lett., 2002, 4, 1151-1153, (synth)
• Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, VGU750; VKZ000; VLA000